Main > > >PERCUTANEOUS CORONARY INTE (PCI).*

---

AbcixiMAb. Adjunct to PCI for Prevention of Cardiac Ischemic Complications ..
(*) Company : Janssen
Patent : Expired
TradeMark: Reopro
UpDate: 2019. 03.28.




Cardio.>Percutaneous Coronary Intervention (PCI). Steerable MicroCa- theter.
CN Approval Date : 2020. 02.20.
EU Approval Date : ?
USA Approval Dare: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2020. 02.23.




Undergoing Percutaneous Coronary
Intervention (PCI) (Including IntraCoro-
nary Stenting). AntiCoagulant. Eptifiba- tide Inj. for IV Use.
Initial USA Approval: 1998.
(*) Company : Merck & Co. Inc.
Patent : Expired.
TradeMark: Integrilin.
UpDate: 2019. 04.15.




Undergoing Percutaneous Coronary Intervention (PCI) with Provisional Use of GlycoProtein IIb/IIIa Inhibitor (GPI)
AntiCoagulant. Bivalirudin for Inj.
Brand.
(*) Company : Medicines Co.
Patent : Expired
TradeMark: Angiomax
Web-Site : www.angiomax.com/
UpDate: 2019. 04.11.




Undergoing Percutaneous Coronary Intervention (PCI) with Provisional Use of GlycoProtein IIb/IIIa Inhibitor (GPI)
AntiCoagulant. Bivalirudin for Inj.
Generics.
USA Launch Date: 2017. 06.06.
(*) Company: Dr. Reddy Labs.
UpDate: 2019. 04.11.




With, or at risk of, Heparin-Induced Thrombocytopenia (HIT) or Heparin-Induced Thrombocytopenia and Thrombosis Syndrome (HITTS), undergoing PCI
AntiCoagulant. Bivalirudin for Inj.
Brand.
(*) Company : Medicines Co.
Patent : Expired
TradeMark: Angiomax
Web-Site : www.angiomax.com/
UpDate: 2019. 04.11.




With, or at risk of, Heparin-Induced Thrombocytopenia (HIT) or Heparin-Induced Thrombocytopenia and Thrombosis Syndrome (HITTS), undergoing PCI
AntiCoagulant. Bivalirudin for Inj.
Generics.
USA Launch Date: 2017. 06.06.
(*) Company: Dr. Reddy Labs.
UpDate: 2019. 04.11.


>PERCUTANEOUS CORONARY INTE (PCI).*'s products
This section has no products